XML 101 R81.htm IDEA: XBRL DOCUMENT
v3.26.1

Share Capital and Other Reserves (Details) |  |  |  |  |  |  |  |  |  |  |  | 1 Months Ended | 12 Months Ended |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Oct. 31, 2025 $ / shares | Oct. 24, 2025 shares | Oct. 03, 2025 shares | Sep. 30, 2025 EUR (€) shares | Sep. 30, 2025 EUR (€) $ / shares shares | Sep. 21, 2025 EUR (€) $ / shares shares | Sep. 15, 2025 shares | Jul. 18, 2025 shares | Jun. 17, 2025 EUR (€) | Mar. 31, 2025 EUR (€) shares | Dec. 31, 2024 USD ($) $ / shares shares | Dec. 31, 2023 EUR (€) shares | Nov. 30, 2025 EUR (€) | Sep. 30, 2025 EUR (€) shares | Sep. 30, 2025 EUR (€) $ / shares shares | Jan. 31, 2023 $ / shares shares | Dec. 31, 2025 EUR (€) € / shares shares | Dec. 31, 2025 EUR (€) € / shares $ / shares shares | Dec. 31, 2024 EUR (€) shares | Dec. 31, 2024 USD ($) $ / shares shares | Dec. 31, 2023 EUR (€) shares | Dec. 31, 2023 USD ($) $ / shares shares | Dec. 31, 2025 $ / shares | Sep. 30, 2025 $ / shares | Jun. 17, 2025 $ / shares shares | Mar. 31, 2025 $ / shares shares | Dec. 31, 2022 shares
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Per share value (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 48.82 |  |  |  |
Ordinary shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 | 1 |  |  |  |  |  |  |  |  |
Over allotment option period |  |  |  |  |  |  |  |  |  |  | 5 years 7 months 6 days | 6 years 7 months 6 days |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate proceeds (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 141,000 |  |  |  |  |  |  |  |  |  |
Conversion of shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 18,500 |  |  |  |  |  |  |  |
Description of Noncash Contribution Received |  |  |  |  |  |  |  |  |  |  |  |  |  | A portion of the PIPE proceeds was received in the form of non-cash contributions, consisting of SOL €1,349, Locked SOL €30,229, USDC of €49,715, USDT of €17,685, and private company common shares with an estimated fair value of €8,434, with the remainder received in cash. |  |  |  |  |  |  |  |  |  |  |  |  |
PIPE shares (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 145,959,000 |  |  |  |  |  |  |  |  |  |
Fair value of warrant liability | € |  |  |  |  |  | € 89,176,000 |  |  |  |  |  |  |  |  |  |  | 251,349,000 | € 251,349,000 |  |  |  |  |  |  |  |  |
Other income (expenses) (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 15,000 |  |  |  |  |  |  |  |  |  |
Grant date fair value (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 90,377 | € 90,377 |  |  |  |  |  |  |  |  |
Expected volatility |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 150.00% |  |  |  |  |  |  |  |  |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3.67% |  |  |  |  |  |  |  |  |  |
Warrants exercise |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 11,339 |  |  |  |  |  |  |  |  |  |
Share price (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 186 |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 186 |  |  |  |  |  |  |  |  |
Pre-funded warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 333,333 |  |  |  |  |  |  |  |  |  |
Exercisable grant-date fair value (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 54,733,000 |  |  |  |  |  |  |  |  |  |
Exercise price of outstanding share options (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.5 | $ 1.5 |  |  |
Number of exercisable warrants exercised |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 333,333 | 333,333 |  |  |  |  |  |  |  |  |
Description of Equity Warrants Issued to Strategic Advisors |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | the Company granted 166, 667 common warrants with an exercise price of $67.5 per share (“Common Warrants 1”) that were immediately exercisable with a grant-date fair value of €26,083, and 166,667 common warrants that are exercisable on a delayed basis with a grant-date fair value of €25,475. The immediately exercisable common warrants were exercised on a cashless basis, resulting in the issuance of 145,425 Class B ordinary shares. |  |  |  |  |  |  |  |  |  |
Granted common warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 600,000 |  |  |  |  |  |  |  |  |  |
Expected Term Share Option |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |
Dividend yield |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  |  |  |  |  |  |  |  |  |
Exercised exchange shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 498,017 |  |  |  |  |  |  |  |  |  |
Share-based compensation expenses (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 2,984,000 |  | € 423,000 |  |  |  |  |  |  |  |
Tranche [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) | $ / shares | $ 67.5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Tranche [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) | $ / shares | 90 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Tranche [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) | $ / shares | $ 112.5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class A Ordinary Share [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Per share value (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.5 |  |  |  |
Designated shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 50,000,000 | 50,000,000 |  |  |  |  |  |  |  |  |
Nominal value | € / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 1 | € 1 |  |  |  |  |  |  |  |  |
Ordinary shares votes per share |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | ten |  |  |  |  |  |  |  |  |  |
Shares held by related parties |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 567,380 |  |  |  |  |  |  |  |  |  |
Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 855
Per share value (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.5 |  |  |  |
Designated shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 500,000 | 500,000 |  |  |  |  |  |  |  |  |
Ordinary shares votes per share |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | one |  |  |  |  |  |  |  |  |  |
Class B Ordinary Shares [Member] | Board of Directors [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Excess shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 54,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Class B Units [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of shares |  | 1,419 | 4,822 |  |  |  | 6,656 | 56,912 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
2023 Initial Public Offering [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued |  |  |  |  |  |  |  |  |  |  |  | 1,500 |  |  |  |  |  |  |  |  | 1,500 |  |  |  |  |  |
Per share value (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 500 |  |  |  |
Offering price per share (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 500 |  |  |  |  |  |  |  |  |  |  |
Offering price (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 465 |  |  |  |  |  |  |  |  |  |  |
Discount rate |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 7.00% |  |  |  |  |  |  |  |  |  |  |
Over allotment option period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 45 days |  |  |  |  |  |  |  |  |  |  |
Shares sold |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 16,500 | 16,500 |  |  |  |  |
Aggregate proceeds (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 6,777,000 |  |  |  |  |  |
purchase price percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 7.00% |  |  |  |  |  |  |  |  |  |
Offering price percentage |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 100.00% |  |  |  |  |  |  |  |  |  |
2023 Initial Public Offering [Member] | Investors [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued |  |  |  |  |  |  |  |  |  |  |  | 15,000 |  |  |  |  |  |  |  |  | 15,000 |  |  |  |  |  |
2023 Initial Public Offering [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 15,000 |  |  |  |  |  |  |  |  |  |  |
Discount rate |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 15.00% |  |  |  |  |  |  |  |  |  |  |
Additional shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,250 |  |  |  |  |  |  |  |  |  |  |
Ordinary shares issued |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,500 | 1,500 |  |  |  |  |  |  |  |  |
2025 Private Placements [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Authorized shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 20,741 |  |
Per share value (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.5 |  |
Aggregate proceeds (in Euro) | € |  |  |  |  |  |  |  |  | € 1,210,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
September 2025 PIPE Transaction [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate proceeds (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  | € 253,900,000 |  |  |  |  |  |  |  |  |  |  |  |  |
PIPE shares (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  | 143,357 |  |  |  |  |  |  |  |  |  |  |  |  |
September 2025 PIPE Transaction [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Nominal value | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.50 |  |  |
Share capital (in Euro) | € |  |  |  | € 2,600,000 | € 2,600,000 |  |  |  |  |  |  |  |  | 2,600,000 | € 2,600,000 |  |  |  |  |  |  |  |  |  |  |  |
other reserves (in Euro) | € |  |  |  | 143,300,000 | 143,300,000 |  |  |  |  |  |  |  |  | 143,300,000 | 143,300,000 |  |  |  |  |  |  |  |  |  |  |  |
Fair value (in Euro) | € |  |  |  | 1,295,894 | 1,295,894 |  |  |  |  |  |  |  |  | 1,295,894 | 1,295,894 |  |  |  |  |  |  |  |  |  |  |  |
Allocation costs (in Euro) | € |  |  |  | € 67,790 | € 67,790 |  |  |  |  |  |  |  |  | 67,790 | € 67,790 |  |  |  |  |  |  |  |  |  |  |  |
PIPE shares (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,602 |  |  |  |  |  |  |  |  |  |  |  |  |
ATM transaction [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate proceeds (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  | € 97,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Securities Purchase Agreements [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 20,000 |  |  |  |  |  |  |  |  |  |
Price per share of warrants exercisable (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 15 |  |  |  |  |  |  |  |  |
Grant date fair value (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 3,228,000 | € 3,228,000 |  |  |  |  |  |  |  |  |
Securities Purchase Agreements [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 62,208 |  |  |  |  |  |  |  |  |  |
Equity Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Equity-based compensation expense (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  | € 261,389 |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants [member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued |  |  |  | 7,304,444 | 7,304,444 |  |  |  |  |  |  |  |  | 7,304,444 | 7,304,444 |  |  |  |  |  |  |  |  |  |  |  |
Pre-funded warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 333,333 |  |  |  |  |  |  |  |  |  |
Exercisable grant-date fair value (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 54,721,000 |  |  |  |  |  |  |  |  |  |
Warrants [member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of exercisable warrants exercised |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 333,333 | 333,333 |  |  |  |  |  |  |  |  |
Warrants [member] | Related Parties [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued |  |  |  | 4,611,111 | 4,611,111 |  |  |  |  |  |  |  |  | 4,611,111 | 4,611,111 |  |  |  |  |  |  |  |  |  |  |  |
October 2025 Amendment to the Strategic Advisor Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share-based compensation expenses (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 261,389,000 |  |  |  |  |  |  |  |  |  |
PIPE Common Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share of warrants exercisable (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 6.75 |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued |  |  |  | 66,666,668 | 66,666,668 |  |  |  |  |  |  |  |  | 66,666,668 | 66,666,668 |  |  |  |  |  |  |  |  |  |  |  |
Expiration term |  |  |  |  |  |  |  |  |  |  |  |  |  | 36 months |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |
PIPE Common Warrants [Member] | September 2025 PIPE Transaction [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value (in Euro) | € |  |  |  | € 1,281,409 | € 1,281,409 |  |  |  |  |  |  |  |  | € 1,281,409 | € 1,281,409 |  |  |  |  |  |  |  |  |  |  |  |
Allocation costs (in Euro) | € |  |  |  | 69,606 | 69,606 |  |  |  |  |  |  |  |  | 69,606 | € 69,606 |  |  |  |  |  |  |  |  |  |  |  |
PIPE Pre Funded Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share of warrants exercisable (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 0.05 |  |  |  |  |  |  |  |  |  |  |  |
Fair value of warrant liability | € |  |  |  | € 1,296,000 | € 1,296,000 |  |  |  |  |  |  |  |  | € 1,296,000 | € 1,296,000 |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued |  |  |  | 5,161,152 | 5,161,152 |  |  |  |  |  |  |  |  | 5,161,152 | 5,161,152 |  |  |  |  |  |  |  |  |  |  |  |
Grant date fair value (in Euro) | € |  |  |  | € 108,500 | € 108,500 |  |  |  |  |  |  |  |  | € 108,500 | € 108,500 |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise |  |  |  |  |  |  |  |  |  |  |  |  |  | 1 |  |  |  |  |  |  |  |  |  |  |  |  |
PIPE Pre Funded Warrants [Member] | September 2025 PIPE Transaction [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value (in Euro) | € |  |  |  | 108,525,000,000 | 108,525,000,000 |  |  |  |  |  |  |  |  | € 108,525,000,000 | 108,525,000,000 |  |  |  |  |  |  |  |  |  |  |  |
Allocation costs (in Euro) | € |  |  |  | € 5,896,000 | € 5,896,000 |  |  |  |  |  |  |  |  | 5,896,000 | € 5,896,000 |  |  |  |  |  |  |  |  |  |  |  |
2023 Revere Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant to purchase period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 years | 5 years |  |  |  |  |
Price per share of warrants exercisable (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 50 |  |  |  |  |
Fair value of warrant liability | € |  |  |  |  |  |  |  |  |  |  |  | € 198,000 |  |  |  |  |  |  |  |  | € 198,000 |  |  |  |  |  |
Option pricing model |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 7,000 |  | 49,000 |  |  | $ 213 |  |  |  |  |
Other income (expenses) (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 42,000 |  | € 164,000 |  |  |  |  |  |  |  |
Expected term |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2.08 |  | 3.08 |  | 4.08 | 4.08 |  |  |  |  |
Expected volatility |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 181.00% |  | 144.00% |  | 124.00% | 124.00% |  |  |  |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3.47% |  | 4.27% |  | 3.84% | 3.84% |  |  |  |  |
Dividend yield |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.00% |  | 0.00% |  | 0.00% | 0.00% |  |  |  |  |
2023 Revere Warrants [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,050 | 1,050 |  |  |  |  |
Equity Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate proceeds (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  | € 26,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share of warrants exercisable (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 13.5 |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued |  |  |  | 12,968 | 12,968 |  |  |  |  |  |  |  |  | 12,968 | 12,968 |  |  |  |  |  |  |  |  |  |  |  |
Purchase percentage |  |  |  |  |  |  |  |  |  |  |  |  |  | 10.00% |  |  |  |  |  |  |  |  |  |  |  |  |
Expiration term |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |  |  |
Grant date fair value (in Euro) | € |  |  |  | € 51 | € 51 |  |  |  |  |  |  |  |  | € 51 | € 51 |  |  |  |  |  |  |  |  |  |  |  |
Expected term |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 |  |  |  |  |  |  |  |  |  |  |  |  |
Expected volatility |  |  |  |  |  |  |  |  |  |  |  |  |  | 100.00% |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise |  |  |  |  |  |  |  |  |  |  |  |  |  | 222 |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Warrants [Member] | Investors [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise |  |  |  |  |  |  |  |  |  |  |  |  |  | 12,968 |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Warrants [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued |  |  |  | 222 | 222 |  |  |  |  |  |  |  |  | 222 | 222 |  |  |  |  |  |  |  |  |  |  |  |
Equity Warrants [Member] | Bottom of Range [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  |  |  |  | 3.96% |  |  |  |  |  |  |  |  |  |  |  |  |
Equity Warrants [Member] | Top of Range [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Risk free interest rate |  |  |  |  |  |  |  |  |  |  |  |  |  | 3.99% |  |  |  |  |  |  |  |  |  |  |  |  |
Boustead Private Placement Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant to purchase period |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |  | 5 years |  |  |  |  |  |  |  |
Purchase of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 13,048 |  |  |  |  |  |  |  |  |  |
Price per share of warrants exercisable (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 5 |  |  |  |  |  |  |
Fair value of warrant liability |  |  |  |  |  |  |  |  |  |  | $ 101 |  |  |  |  |  | € 50,000 | € 50,000 |  | $ 101 |  |  |  |  |  |  |
Private placement warrants offerings |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 54,500 |  |  |  |  |  |  |  |
Boustead Private Placement Warrants [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 6,118 | 6,118 |  |  |  |  |  |  |  |  |
Series A Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants exercise |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 44,128 |  |  |  |  |  |  |  |  |  |
Series A Warrant [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 3,114 | 3,114 |  |  |  |  |  |  |  |  |
Class B Warrant [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Outstanding warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 10,535
Warrant FA 1 [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share of warrants exercisable (in Dollars per share) | $ / shares |  |  |  |  |  | € 45 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of warrant liability | € |  |  |  |  |  | € 41,490,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued |  |  |  |  |  | 307,528 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cashless warrants exercised |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,813,921 |  |  |  |  |  |  |  |  |  |
Warrant FA 1 [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Underlying percentage of warrants |  |  |  |  |  | 5.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant FA 2 [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of warrant liability | € |  |  |  |  |  | € 44,456,000,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued |  |  |  |  |  | 333,333 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cashless warrants exercised |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 2,908,404 |  |  |  |  |  |  |  |  |  |
Warrant FA 2 [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share of warrants exercisable (in Dollars per share) | $ / shares |  |  |  |  |  | € 67.5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Underlying percentage of warrants |  |  |  |  |  | 5.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrant FA 3 [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fair value of warrant liability | € |  |  |  |  |  | € 3,483,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Warrants issued |  |  |  |  |  | 25,806 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cashless warrants exercised |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 236,370 |  |  |  |  |  |  |  |  |  |
Warrant FA 3 [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share of warrants exercisable (in Dollars per share) | $ / shares |  |  |  |  |  | € 44.5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Underlying percentage of warrants |  |  |  |  |  | 5.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Boustead Private Placement (“PIPE”) Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Expected term |  |  |  |  |  | 5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Expected volatility |  |  |  |  |  | 150.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Risk free interest rate |  |  |  |  |  | 3.68% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share price (in Dollars per share) | $ / shares |  |  |  |  |  | € 16 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Boustead Private Placement (“PIPE”) Warrants [Member] | Bottom of Range [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) | $ / shares |  |  |  |  |  | 44.5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Boustead Private Placement (“PIPE”) Warrants [Member] | Top of Range [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Exercise price (in Dollars per share) | $ / shares |  |  |  |  |  | € 67.5 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series S6 Warrants [Member] | Securities Purchase Agreements [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Grant date fair value (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 10,040,000 | € 10,040,000 |  |  |  |  |  |  |  |  |
Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Authorized shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,053,000,000 | 1,053,000,000 |  |  |  |  |  |  |  |  |
Shares issued |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,003,000,000 | 1,003,000,000 |  |  |  |  |  |  |  |  |
Per share value (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 0.005 |  |  |  |
Preference Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,002,500,000 | 1,002,500,000 |  |  |  |  |  |  |  |  |
Per share value (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.5 |  |  |  |
Series A Preferred Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of shares |  | 711,400 |  |  |  |  |  | 711,400 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series A Preferred Shares [Member] | Class B Units [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of shares |  | 56,912 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series A Preferred Shares [Member] | 2024 Private Placements [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Per share value (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 5 |  |  |  |  |  |  |  |  | $ 5 |  |  |  |  |  |  |
Offering shares |  |  |  |  |  |  |  |  |  |  | 545,000 |  |  |  |  |  |  |  |  | 545,000 |  |  |  |  |  |  |
Net proceeds (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 2,623,000 |  |  |  |  |  |  |  |
Series A Preferred Shares [Member] | 2024 Private Placements [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (8) |  |  |  |  |  |  |  |
Series A Preferred Shares [Member] | 2025 Private Placements [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 186,400 |
Per share value (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 5 |
Aggregate proceeds (in Euro) | € |  |  |  |  |  |  |  |  |  | € 810,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series A Preferred Shares [Member] | 2025 Private Placements [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of shares |  |  |  |  |  |  |  |  |  | 8 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series A Preferred Shares [Member] | Boustead Private Placement Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 38,150 |  |  |  |  |  |  |  |
Series B Preferred Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Conversion of shares |  | 18,519 | 60,277 |  |  |  | 83,194 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Series B Preferred Shares [Member] | 2025 Private Placements [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Offering price per share (in Dollars per share) | $ / shares |  |  |  |  | € 5.4 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Aggregate proceeds (in Euro) | € |  |  |  | € 689,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Offering shares |  |  |  | 161,990 | 161,990 |  |  |  |  |  |  |  |  | 161,990 | 161,990 |  |  |  |  |  |  |  |  |  |  |  |
Number of shares underlying percentage |  |  |  | 10.00% |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Price per share (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 13.5 |  |  |
Series B Preferred Shares [Member] | September 2025 PIPE Transaction [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued |  |  |  | 6,150,552 | 6,150,552 |  |  |  |  |  |  |  |  | 6,150,552 | 6,150,552 |  |  |  |  |  |  |  |  |  |  |  |
Series B Preferred Shares [Member] | Boustead Private Placement Warrants [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Purchase of warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 11,339 |  |  |  |  |  |  |  |  |  |
Price per share of warrants exercisable (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 5.4 |  |  |  |  |  |  |  |  |
Fair value of warrant liability | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 359,000 | € 359,000 |  |  |  |  |  |  |  |  |
Contractual term |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |
Excess Issuance of Class B Ordinary Shares [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Per share value (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 0.5 |  |  |
Two Thousand Twenty Five Conversion of Shares [Member] | Class A Ordinary Share [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Reclassified shares |  |  |  | 31,380 | 31,380 |  |  |  |  |  |  |  |  | 31,380 | 31,380 |  |  |  |  |  |  |  |  |  |  |  |
Two Thousand Twenty Five Conversion of Shares [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares issued |  |  |  | 63,380 | 63,380 |  |  |  |  |  |  |  |  | 63,380 | 63,380 |  |  |  |  |  |  |  |  |  |  |  |
Other Reserves [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
PIPE shares (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | € 143,357,000 |  |  |  |  |  |  |  |  |  |
Other Reserves [Member] | September 2025 PIPE Transaction [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
PIPE shares (in Euro) | € |  |  |  |  |  |  |  |  |  |  |  |  |  | € 145,959 |  |  |  |  |  |  |  |  |  |  |  |  |
Subscription Receivable [Member] | Class B Ordinary Shares [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share Capital and Other Reserves [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share capital (in Euro) | € |  |  |  | € 22 | € 22 |  |  |  |  |  |  |  |  | € 22 | € 22 |  |  |  |  |  |  |  |  |  |  |  |
Excess shares |  |  |  |  |  |  |  |  |  |  |  |  |  | 54,000 |  |  |  |  |  |  |  |  |  |  |  |  |

X
- Definition Amount of transaction costs that were allocated. + References No definition available. + Details
Name: | brer_AllocationOfTransactionCosts
Namespace Prefix: | brer_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Cashless warrants exercise. + References No definition available. + Details
Name: | brer_CashlessWarrantsExerciseinShares
Namespace Prefix: | brer_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. + References No definition available. + Details
Name: | brer_CommonStocksSharesAuthorized
Namespace Prefix: | brer_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. + References No definition available. + Details
Name: | brer_CommonStocksSharesIssued
Namespace Prefix: | brer_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Description of equity warrants issued to strategic advisors. + References No definition available. + Details
Name: | brer_DescriptionOfEquityWarrantsIssuedToStrategicAdvisors
Namespace Prefix: | brer_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of noncash contribution received. + References No definition available. + Details
Name: | brer_DescriptionOfNoncashContributionReceived
Namespace Prefix: | brer_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of designated shares. + References No definition available. + Details
Name: | brer_DesignatedOrdinaryShares
Namespace Prefix: | brer_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of equity-based compensation expenses. + References No definition available. + Details
Name: | brer_EquityBasedCompensationExpenses
Namespace Prefix: | brer_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of excess shares issued. + References No definition available. + Details
Name: | brer_ExcessIssuanceOfShares
Namespace Prefix: | brer_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of exercisable grant date fair value. + References No definition available. + Details
Name: | brer_ExercisableGrantDateFairValue
Namespace Prefix: | brer_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of warrants exercised. + References No definition available. + Details
Name: | brer_ExerciseOfWarrants
Namespace Prefix: | brer_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares exercised exchange. + References No definition available. + Details
Name: | brer_ExercisedExchangeShares
Namespace Prefix: | brer_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The option life of share options. + References No definition available. + Details
Name: | brer_ExpectedTermShareOption
Namespace Prefix: | brer_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares granted common warrants. + References No definition available. + Details
Name: | brer_GrantedCommonWarrants
Namespace Prefix: | brer_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of warrants issued. + References No definition available. + Details
Name: | brer_IssuanceOfWarrants
Namespace Prefix: | brer_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow from issuing shares. + References No definition available. + Details
Name: | brer_NetProceeds
Namespace Prefix: | brer_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Nominal value per share. + References No definition available. + Details
Name: | brer_NominalValuePerShare
Namespace Prefix: | brer_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of exercisable warrants exercised. + References No definition available. + Details
Name: | brer_NumberOfExercisableWarrantsExercised
Namespace Prefix: | brer_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares offering private placement. + References No definition available. + Details
Name: | brer_NumberOfSharesOfferingPrivatePlacement
Namespace Prefix: | brer_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares underlying percentage. + References No definition available. + Details
Name: | brer_NumberOfSharesUnderlyingPercentage
Namespace Prefix: | brer_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of offering price per share. + References No definition available. + Details
Name: | brer_OfferingPricePerShare
Namespace Prefix: | brer_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Offering price percentage. + References No definition available. + Details
Name: | brer_OfferingPricePercentage
Namespace Prefix: | brer_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights. + References No definition available. + Details
Name: | brer_OrdinarySharesVotes
Namespace Prefix: | brer_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Other income (expenses). + References No definition available. + Details
Name: | brer_OtherIncomeexpenses
Namespace Prefix: | brer_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition PIPE Share issuances. + References No definition available. + Details
Name: | brer_PIPEShareIssuances
Namespace Prefix: | brer_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Percentage of discount rate. + References No definition available. + Details
Name: | brer_PercentageOfDiscountRate
Namespace Prefix: | brer_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Percentage of offering price. + References No definition available. + Details
Name: | brer_PercentageOfOfferingPrice
Namespace Prefix: | brer_
Data Type: | dtr:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares pre-funded warrants. + References No definition available. + Details
Name: | brer_PrefundedWarrants
Namespace Prefix: | brer_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the percentage of purchase of shares. + References No definition available. + Details
Name: | brer_PurchaseOfSharesPercentage
Namespace Prefix: | brer_
Data Type: | dtr1:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Purchase price. + References No definition available. + Details
Name: | brer_PurchasePrice
Namespace Prefix: | brer_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Purchase to additional shares. + References No definition available. + Details
Name: | brer_PurchaseToAdditionalShares
Namespace Prefix: | brer_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Purchase Warrant Term. + References No definition available. + Details
Name: | brer_PurchaseWarrantTerm
Namespace Prefix: | brer_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares that were reclassified. + References No definition available. + Details
Name: | brer_ReclassificationOfShares
Namespace Prefix: | brer_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of shares shares sold for cash. + References No definition available. + Details
Name: | brer_ShareSoldForCash
Namespace Prefix: | brer_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares converted. + References No definition available. + Details
Name: | brer_SharesConverted
Namespace Prefix: | brer_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of shares held by related parties. + References No definition available. + Details
Name: | brer_SharesHeldByRelatedParties
Namespace Prefix: | brer_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Underlying of price per share. + References No definition available. + Details
Name: | brer_UnderlyingOfPricePerShare
Namespace Prefix: | brer_
Data Type: | dtr1:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Represents the percentage underlying shares. + References No definition available. + Details
Name: | brer_UnderlyingSharesPercentage
Namespace Prefix: | brer_
Data Type: | dtr1:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Warrant contractual term. + References No definition available. + Details
Name: | brer_WarrantContractualTerm
Namespace Prefix: | brer_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share of warrants exercisable. + References No definition available. + Details
Name: | brer_WarrantExercisable
Namespace Prefix: | brer_
Data Type: | dtr:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition Warrant expiration term. + References No definition available. + Details
Name: | brer_WarrantExpirationTerm
Namespace Prefix: | brer_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number shares of warrant purchase. + References No definition available. + Details
Name: | brer_WarrantPurchase
Namespace Prefix: | brer_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash outflow for futures contracts, forward contracts, option contracts and swap contracts except when the contracts are held for dealing or trading purposes or the payments are classified as financing activities. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 7 -IssueDate 2025-01-01 -Paragraph 16 -Subparagraph g -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16_g&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_CashPaymentsForFutureContractsForwardContractsOptionContractsAndSwapContractsClassifiedAsInvestingActivities
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The option life of share options granted. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DescriptionOfOptionLifeShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfClassesOfShareCapitalLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The exercise price of outstanding share options. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_d&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_ExercisePriceOfOutstandingShareOptions2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The exercise price of share options granted. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_ExercisePriceShareOptionsGranted2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The percentage of an expected dividend used to calculate the fair value of share options granted. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2025-01-01 -Paragraph 25 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_25&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_FinancialLiabilitiesAtFairValue
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The nominal value of capital arising from issuing ordinary shares. [Refer: Issued capital] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 78 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_IssuedCapitalOrdinaryShares
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 24 -IssueDate 2025-01-01 -Paragraph 17 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_17_e&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_KeyManagementPersonnelCompensationSharebasedPayment
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares authorised. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph B10 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_i&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 160 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_i&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 79 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_i&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_NumberOfSharesAuthorised
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of shares issued by the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 106 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_NumberOfSharesIssued
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The number of shares that have been authorised and issued, reduced by treasury shares held. [Refer: Treasury shares] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 160 -Subparagraph a -Clause iv -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_iv&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph B10 -Subparagraph a -Clause iv -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_iv&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 79 -Subparagraph a -Clause iv -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_iv&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_NumberOfSharesOutstanding
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition A component of equity representing reserves within equity, not including retained earnings. [Refer: Retained earnings] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph B9 -Subparagraph f -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 78 -Subparagraph e -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_OtherReserves
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The nominal value per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph B10 -Subparagraph a -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_iii&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 160 -Subparagraph a -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_iii&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 79 -Subparagraph a -Clause iii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_iii&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_ParValuePerShare
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow from issuing shares. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IAS -Number 7 -IssueDate 2025-01-01 -Paragraph 17 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_a&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_ProceedsFromIssuingShares
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares reserved for issue under options and contracts for the sale of shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph B10 -Subparagraph a -Clause vii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_vii&doctype=Appendix&subtype=B -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 160 -Subparagraph a -Clause vii -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_vii&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 79 -Subparagraph a -Clause vii -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_vii&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_SharesReservedForIssueUnderOptionsAndContractsForSaleOfShares
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The amount of warrant liabilities. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Note Expiry date 2027-01-01 -Name IAS -Number 1 -IssueDate 2025-01-01 -Paragraph 55 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_WarrantLiability
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The weighted average fair value of share options granted during the period at the measurement date. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 47 -Subparagraph a -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_WeightedAverageFairValueAtMeasurementDateShareOptionsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -Subparagraph d -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_d&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average share price used as input to the option pricing model to calculate the fair value of share options granted. [Refer: Option pricing model [member]; Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 47 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_a_i&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_WeightedAverageSharePriceShareOptionsGranted2019
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | brer_VestingPeriodAxis=brer_TrancheOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | brer_VestingPeriodAxis=brer_TrancheTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | brer_VestingPeriodAxis=brer_TrancheThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfOrdinarySharesAxis=brer_ClassAOrdinaryShareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfOrdinarySharesAxis=brer_ClassBOrdinaryShareMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=srt_DirectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfOrdinarySharesAxis=brer_ClassBUnitsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | brer_PlansNameAxis=brer_InitialPublicOffering2023Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=brer_InvestorsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | brer_PlansNameAxis=brer_PrivatePlacement2025Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | brer_PlansNameAxis=brer_September2025PIPETransactionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | brer_PlansNameAxis=brer_ATMTransactionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | brer_AgreementsAxis=brer_SecuritiesPurchaseAgreementsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfAntidilutiveInstrumentsAxis=brer_EquityWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfAntidilutiveInstrumentsAxis=ifrs-full_WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfAntidilutiveInstrumentsAxis=brer_October2025AmendmentToTheStrategicAdvisorWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=brer_PIPECommonWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=brer_PIPEPreFundedWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=brer_RevereWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=brer_EquityWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=brer_BousteadPrivatePlacementWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=brer_SeriesAWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=brer_ClassBWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=brer_WarrantFA1Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=brer_WarrantFA2Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=brer_WarrantFA3Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=brer_BousteadPrivatePlacementPIPEWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfFinancialInstrumentsAxis=brer_SeriesS6WarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_PreferenceSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=brer_SeriesAPreferredSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | brer_PlansNameAxis=brer_PrivatePlacement2024Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=brer_SeriesBPreferredSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=brer_ExcessIssuanceOfClassBOrdinarySharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ComponentsOfEquityAxis=brer_TwoThousandTwentyFiveConversionOfSharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ComponentsOfEquityAxis=ifrs-full_OtherReservesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ComponentsOfEquityAxis=brer_SubscriptionReceivableMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |